Intravenous products: The Herald News report “Germs are serious business for Matt Reavill. His 59-year-old father survived heart surgery in 1994 only to die of an ensuing staph infection. The infection came from a central line catheter that was inserted into his dads heart through a large vein in his neck. He languished for 22 days, Reavill said.
Central lines are used to administer medications and get diagnostic readings in patients. Now Reavill has invented a device that he says could have prevented his dads infection and thousands of others by stopping germs from entering the body during placement of a central line.
The invention, called the ReavillMED CV, won an international innovation award last month at the Health Pitch Battlefield competition sponsored by OmniCompete in London. Reavill pitted his product against four others, including a hip replacement that allowed patients to walk eight hours after surgery. Each competitor had just six minutes to describe their invention.”
Click here for the full story.